Evidence map›Paper›PMID 28066953›Full record

ArticleNeurogastroenterology and motility2017

Diabetic and idiopathic gastroparesis is associated with loss of CD206-positive macrophages in the gastric antrum.

M Grover, C E Bernard, P J Pasricha, H P Parkman, S J Gibbons, J Tonascia, K L Koch, R W McCallum, I Sarosiek, W L Hasler and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Neurogastroenterology and motility, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. A pilot genome-wide association study meta-analysis of gastroparesis.United European gastroenterology journal · 2023
    Pooled it
  3. Trial
  4. Observational
  5. Article
  6. Intestinal muscularis in health and disease.Communications biology · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Pharmacologic treatments for gastroparesis.Pharmacological reviews · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Postoperative delayed gastric emptying: may gut microbiota play a role?Frontiers in cellular and infection microbiology · 2024
    Review
  19. Review
  20. CaPhysiological reviews · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 12 institutions in 1 country.

M GroverEnteric NeuroScience Program, Mayo Clinic, Rochester, MN, USA.
C E BernardEnteric NeuroScience Program, Mayo Clinic, Rochester, MN, USA.
P J PasrichaJohns Hopkins School of Medicine, Baltimore, MD, USA.
H P ParkmanTemple University, Philadelphia, PA, USA.
S J GibbonsEnteric NeuroScience Program, Mayo Clinic, Rochester, MN, USA.
J TonasciaJohns Hopkins University Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
K L KochWake Forest University, Winston-Salem, NC, USA.
R W McCallumTexas Tech University, El Paso, TX, USA.
I SarosiekTexas Tech University, El Paso, TX, USA.
W L HaslerUniversity of Michigan, Ann Arbor, MI, USA.
L A B NguyenStanford University, Palo Alto, CA, USA.
T L AbellUniversity of Louisville, Louisville, KY, USA.
W J SnapeCalifornia Pacific Medical Center, San Francisco, CA, USA.
M L KendrickEnteric NeuroScience Program, Mayo Clinic, Rochester, MN, USA.
T A KelloggEnteric NeuroScience Program, Mayo Clinic, Rochester, MN, USA.
T J McKenzieEnteric NeuroScience Program, Mayo Clinic, Rochester, MN, USA.
F A HamiltonNational Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA.
G FarrugiaEnteric NeuroScience Program, Mayo Clinic, Rochester, MN, USA.
NIDDK Gastroparesis Clinical Research Consortium (GpCRC)
Mayo Clinic in Arizona · USMayo Clinic in Florida · USJohns Hopkins University · USTexas Tech University · USCalifornia Pacific Medical Center · USMayo Clinic · USNational Institute of Diabetes and Digestive and Kidney Diseases · USStanford University · USTemple University · USUniversity of Louisville · USUniversity of Michigan–Ann Arbor · USWake Forest University · US

Funding

PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
Gastroparesis Consortium Continuation-Data Coordinating CenterU01DK074008 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI TONASCIA, JAMES A · 2006 to 2015
$17.4M
PGpR2 Year 4 Supplement for the Scientific Data Research Center (SDRC) of the GpCRC 4U24DK074008 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI David M Shade · 2017 to 2026
$11.7M
Subtypes of GastroparesisU01DK073974 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Baharak Moshiree · 2006 to 2026
$7.4M
Temple University Gastroparesis Clinical CenterU01DK073975 · NIDDK · TEMPLE UNIV OF THE COMMONWEALTH · PI HENRY PAUL PARKMAN · 2006 to 2026
$7.4M
U of L Clinical Center to Investigate the Pathogenesis, Etiology, and Treatment of Gastroparesis through the NIDDK Gastroparesis ConsortiumU01DK074007 · NIDDK · UNIVERSITY OF MISSISSIPPI MED CTR · PI Thomas Lyman Abell · 2006 to 2026
$7.0M
Molecular Approaches to Pathogenesis/Therapy in GastropaU01DK073983 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI PANKAJ J PASRICHA · 2006 to 2026
$6.8M
The GpCRC Pediatric Gastroparesis Registry 2 (PGpR2): Characterization and Clinical Course of Symptoms and Gastric Emptying in Pediatric, Adolescent, and Young Adult Participants with Symptoms of GastU01DK074035 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Irene Sarosiek · 2008 to 2026
$6.7M
Visceral Afferent Dysfunction in Diabetic GastropathyU01DK073985 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HASLER, WILLIAM L · 2006 to 2015
$2.7M
"Barrier function alterations in post-infectious irritable bowel syndrome"K23DK103911 · NIDDK · MAYO CLINIC ROCHESTER · PI GROVER, MADHUSUDAN · 2015 to 2019
$804k
NIDDK NIH HHS K23 DK103911NIDDK NIH HHS P30 DK084567NIDDK NIH HHS U01 DK073974NIDDK NIH HHS U01 DK073975NIDDK NIH HHS U01 DK073983NIDDK NIH HHS U01 DK073985NIDDK NIH HHS U01 DK074007NIDDK NIH HHS U01 DK074008NIDDK NIH HHS U01 DK074035NIDDK NIH HHS U24 DK074008
6 · The paper itself

Abstract

backgroundAnimal studies have increasingly highlighted the role of macrophages in the development of delayed gastric emptying. However, their role in the pathophysiology of human gastroparesis is unclear. Our aim was to determine changes in macrophages and other cell types in the gastric antrum muscularis propria of patients with diabetic and idiopathic gastroparesis.

methodsFull thickness gastric antrum biopsies were obtained from patients enrolled in the Gastroparesis Clinical Research Consortium (11 diabetic, 6 idiopathic) and 5 controls. Immunolabeling and quantitative assessment was done for interstitial cells of Cajal (ICC) (Kit), enteric nerves protein gene product 9.5, neuronal nitric oxide synthase, vasoactive intestinal peptide, substance P, tyrosine hydroxylase), overall immune cells (CD45) and anti-inflammatory macrophages (CD206). Gastric emptying was assessed using nuclear medicine scintigraphy and symptom severity using the Gastroparesis Cardinal Symptom Index.

resultsBoth diabetic and idiopathic gastroparesis patients showed loss of ICC as compared to controls (Mean [standard error of mean]/hpf: diabetic, 2.28 [0.16]; idiopathic, 2.53 [0.47]; controls, 6.05 [0.62]; P=.004). Overall immune cell population (CD45) was unchanged but there was a loss of anti-inflammatory macrophages (CD206) in circular muscle (diabetic, 3.87 [0.32]; idiopathic, 4.16 [0.52]; controls, 6.59 [1.09]; P=.04) and myenteric plexus (diabetic, 3.83 [0.27]; idiopathic, 3.59 [0.68]; controls, 7.46 [0.51]; P=.004). There was correlation between the number of ICC and CD206-positive cells (r=.55, P=.008). Enteric nerves (PGP9.5) were unchanged: diabetic, 33.64 (3.45); idiopathic, 41.26 (6.40); controls, 46.80 (6.04).

conclusionLoss of antral CD206-positive anti-inflammatory macrophages is a key feature in human gastroparesis and it is associates with ICC loss.

Indexed as

AdultDiabetes ComplicationsEnteric Nervous SystemFemaleFibrosisGastroparesisHumansInterstitial Cells of CajalLectins, C-TypeMacrophagesMaleMannose-Binding LectinsMannose ReceptorMiddle AgedPyloric AntrumReceptors, Cell SurfaceLectins, C-TypeMannose-Binding LectinsMannose ReceptorReceptors, Cell Surfaceenteric nervous systemgastrointestinal motilityimmune cellsinterstitial cells of Cajalmacrophages

Identifiers

PMID28066953
PMCPMC5423829
OpenAlexW2570587699

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.